ZHONG Xiao-dan,WEN Bin,SUN Hai-tao,et al.Mechanism of Biejiajian Wan Against EMT of Hepatocellular Carcinoma Cells Through NF-κB Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(01):24-32.
ZHONG Xiao-dan,WEN Bin,SUN Hai-tao,et al.Mechanism of Biejiajian Wan Against EMT of Hepatocellular Carcinoma Cells Through NF-κB Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(01):24-32. DOI: 10.13422/j.cnki.syfjx.20212421.
Mechanism of Biejiajian Wan Against EMT of Hepatocellular Carcinoma Cells Through NF-κB Signaling Pathway
To investigate the effect of Biejiajian Wan (BJJW) on transforming growth factor-
β
1
(TGF-
β
1
)-induced epithelial-mesenchymal transition (EMT) of HepG2 cells, and explore its mechanism against EMT of hepatocellular carcinoma cells.
Method
2
HepG2 cells were randomly divided into a blank group, a TGF-
β
1
model group (10 μg·L
-1
TGF-
β
1
), a low-dose BJJW group (10 μg·L
-1
TGF-
β
1
+0.55 g·kg
-1
BJJW), a medium-dose BJJW group (10 μg·L
-1
TGF-
β
1
+1.1 g·kg
-1
BJJW), a high-dose BJJW group (10 μg·L
-1
TGF-
β
1
+2.2 g·kg
-1
BJJW), and a sorafenib group (10 μg·L
-1
TGF-
β
1
+0.03 g·kg
-1
sorafenib). The EMT model was induced by 10 μg·L
-1
TGF-
β
1
in
HepG2 cells. After treatment with corresponding medicated serum, cell counting kit -8 (CCK-8) assay was used to detect cell proliferation. Cell migration ability was detected by the Transwell assay and wound healing assay. The protein expression related to EMT and nuclear factor-kappa B (NF-
κ
B) signaling pathway was detected by cell immunofluorescence assay and Western blot.
Result
2
Compared with the blank group 4 days later, the TGF-
β
1
model group showed fusiform and loose cells with widened gap and antennae reaching out, decreased protein expression of E-cadherin (
P
<
0.05), and increased protein expression of N-cadherin and vimentin (
P
<
0.05), which indicated that the EMT model was properly induced in HepG2 cells by TGF-
β
1
stimulation for 4 days. After 48 hours of treatment with the corresponding medicated serum, each medication group showed inhibited proliferation of HepG2 cells that had undergone EMT, especially the low- and high-dose BJJW groups (
P
<
0.01), and the medium-dose BJJW group showed increased E-cadherin protein expression (
P
<
0.05) and decreased p-p65, N-cadherin, and vimentin protein expression (
P
<
0.05), as compared with the TGF-
β
1
model group. As revealed by the transwell assay and wound healing assay, TGF-
β
1
enhanced the migration ability of HepG2 cells (
P
<
0.05,
P
<
0.01) compared with the results in the blank group, compared with the TGF-
β
1
model group, the medication groups showed inhibited migration ability of HepG2 cells (
P
<
0.05,
P
<
0.01). Compared with the blank group, the TGF-
β
1
model group promoted the expression of p65 and Snail into the nucleus. Compared with the TGF-
β
1
model group, the medication groups inhibited the expression of p65 and Snail into the nucleus.
Conclusion
2
BJJW may inhibit the EMT, proliferation, and migration of HepG2 cells induced by TGF-
β
1
by suppressing the NF-
κ
B signaling pathway to exert an anti-hepatocellular carcinoma effect.
SUN J L , CHEN W C , WEN B , et al . Biejiajian pill inhibits carcinogenesis and metastasis via the Akt/GSK-3beta/Snail signaling pathway in hepatocellular carcinoma [J]. Front Pharmacol , 2021 , doi: 10.3389/fphar.2021.610158 http://dx.doi.org/10.3389/fphar.2021.610158 .
PASTUSHENKO I , BLANPAIN C . EMT transition states during tumor progression and metastasis [J]. Trends Cell Biol , 2019 , 29 ( 3 ): 212 - 226 .
LI Y , LIN Z , CHEN B , et al . Ezrin/NF-kappa B activation regulates epithelial- mesenchymal transition induced by EGF and promotes metastasis of colorectal cancer [J]. Biomed Pharmacother , 2017 , doi: 10.1016/j.biopha.2017.05.058 http://dx.doi.org/10.1016/j.biopha.2017.05.058 .
SYED V . TGF-beta signaling in cancer [J]. J Cell Biochem , 2016 , 117 ( 6 ): 1279 - 1287 .
JIN S , GAO J , QI Y , et al . TGF-beta1 fucosylation enhances the autophagy and mitophagy via PI3K/Akt and Ras-Raf-MEK-ERK in ovarian carcinoma [J]. Biochem Biophys Res Commun , 2020 , 524 ( 4 ): 970 - 976 .
WANG B , LIU T , WU J C , et al . STAT3 aggravates TGF- β 1 -induced hepatic epithelial-to-mesenchymal transition and migration [J]. Biomed Pharmacother , 2018 , doi: 10.1016/j.biopha.2017.12.035 http://dx.doi.org/10.1016/j.biopha.2017.12.035 .
SUN Y , ZHOU Q M , LU Y Y , et al . Resveratrol inhibits the migration and metastasis of MDA-MB-231 human breast cancer by reversing TGF- β 1 -induced epithelial-Mesenchymal transition [J]. Molecules , 2019 , 24 ( 6 ): 1131 .
REN D , YANG Q , DAI Y , et al . Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-kappa B signaling pathway [J]. Mol Cancer , 2017 , 16 ( 1 ): 117 .
DONG C , WU Y , YAO J , et al . G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer [J]. J Clin Invest , 2012 , 122 ( 4 ): 1469 - 1486 .
TANIGUCHI K , KARIN M . NF-kappa B, inflammation, immunity and cancer: coming of age [J]. Nat Rev Immunol , 2018 , 18 ( 5 ): 309 - 324 .
LI W , LI S , YANG J , et al . ITGBL1 promotes EMT, invasion and migration by activating NF-kappa B signaling pathway in prostate cancer [J]. Onco Targets Ther , 2019 , doi: 10.2147/OTT.S200082 http://dx.doi.org/10.2147/OTT.S200082 .
ZHOU J , ZHENG S , LIU T , et al . MCP2 activates NF-kappa B signaling pathway promoting the migration and invasion of ESCC cells [J]. Cell Biol Int , 2018 , 42 ( 3 ): 365 - 372 .
LIU J , WU Z , HAN D , et al . Mesencephalic astrocyte-derived neurotrophic factor inhibits liver cancer through small ubiquitin-related modifier (SUMO) ylation-related suppression of NF-kappa B/snail signaling pathway and epithelial-mesenchymal transition [J]. Hepatology , 2020 , 71 ( 4 ): 1262 - 1278 .
Effect of Qingre Huashi Sanjie Enema Prescription on MCP-1,TGF-β1,IL-6,and T Lymphoid Subsets in Patients with Sequelae of Pelvic Inflammatory Disease with Syndrome of Combined Dampness, Heat, and Stasis
Chinese Medicine Regulates Hepatocellular Carcinoma-related Signaling Pathways: A Review
Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice
Intervention Mechanism of Biejiajian Wan on Primary Liver Cancer by Regulating lncRNA SNHG5/miRNA-26a-5p/GSK-3β Signal Axis
Anti-liver Cancer Mechanisms of Biejiajian Wan and Clinical Research: A Review
Related Author
CHEN Wenxiao
ZHANG Chen
YU Xijing
YU Chun
GAO Fen
ZHENG Lanlan
GUO Cai
HE Yanfang
Related Institution
Nanchang Hongdu Hospital of TCM
Ganzhou Hospital of Traditional Chinese Medicine(TCM)
Nanchang Medical College
First School of Clinical Medicine, Gansu University of Chinese Medicine
Key Laboratory of Dunhuang Medicine, Ministry of Education, Gansu Provincial Key Laboratory for Molecular Medicine of Major Diseases and Traditional Chinese Medicine Prevention and Treatment Research, Gansu University of Chinese Medicine